Eli Lilly stated "Lilly is deeply concerned that products fraudulently claimed by compounding pharmacies or counterfeiters to be FDA-approved tirzepatide, Mounjaro, or Zepbound may expose patients to serious health risks." Novo Nordisk said its lawsuits "aim to protect US patients and consumers from deceptive marketing by these entities as well as potentially harmful and improperly compounded drugs claiming to contain semaglutide." At least seven deaths linked to compounded versions of semaglutide, the active ingredient in these medications, have been reported to the FDA
Special warning for tirzepatide: delayed gastric emptying induced by tirzepatide may reduce the exposure and efficacy of oral hormonal contraceptives
[DOI] [PubMed] [Google Scholar] 171.Sandborn WJ, Feagan BG, Marano C, Zhang H, Strauss R, Johanns J, et al
Paracetamol is generally the safest first-line option for mild to moderate headaches whilst taking Rybelsus
BPC-157 is not FDA-approved for human use and currently appears on the FDAs Category 2 list of compounds restricted from routine compounding
